MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Putaminal dopamine depletion in de novo Parkinson’s disease predicts future development of wearing-off

    S.J. Chung, Y. Lee, J.S. Oh, J.S. Kim, P.H. Lee, Y.H. Sohn (Goyang, Republic of Korea)

    Objective: The present study aimed to investigate whether the level of presynaptic dopamine neuronal loss predicts future development of wearing-off in de novo Parkinson’s disease.…
  • 2018 International Congress

    Optimization of deep brain stimulation in STN among patients with Parkinson’s disease using a novel EEG-based tool

    D. Sand, Z. Peremen, D. Haor, S. Israeli-Korn, D. Arkadir, M. Abu Snineh, Z. Israel, S. Hassin-Baer, R. Eitan, H. Bergman, A. Geva (Jerusalem and Herzlia, Israel)

    Objective: The current study aims to develop an innovative method for objective differentiation between the locations of the four DBS contacts in the various parts…
  • 2018 International Congress

    Behavior and PET Imaging Study in Parkinsonian Rat Models Induced by Injection of 6-OHDA in Medial Forebrain Bundle

    W. Xian, Q. Guo, L. Jiang, Z. Pei, L. Chen (Guangzhou, China)

    Objective: To employ behavioral test, positron emission tomography (PET) imaging and immunohistochemical staining to assess the changes of brain function and dopaminergic system in rat…
  • 2018 International Congress

    Motor cortical inhibitory and facilitatory circuit interactions in Parkinson’s disease

    J. Saravanamuttu, N. Radhu, K. Udupa, C. Gunraj, J. Baarbé, R. Chen (Toronto, ON, Canada)

    Objective: To determine how intracortical circuits interact with one another in Parkinson’s disease. Background: Using transcranial magnetic stimulation (TMS), previous work has established that motor…
  • 2018 International Congress

    The difference in cerebellar blood flow reduction in multiple system atrophy and Parkinson’s disease

    N. Murakami, W. Sako, S. Haji, Y. Izumi, R. Kaji (Tokushima, Japan)

    Objective: The aim of this study is to determine if cerebral blood flow (CBF) reduction in the cerebellum could be a tool for differential diagnosis…
  • 2018 International Congress

    Return to automaticity: cortical activity during gait in Parkinson’s disease

    S. Stuart, R. Morris, G. Booth, M. Mancini (Portland, OR, USA)

    Objective: This study investigated pre-frontal cortex (PFC) activation while walking in older adults and people with Parkinson’s disease (PD). We specifically examined 1) PFC activation…
  • 2018 International Congress

    Neuroprotective effect of exogenous melatonin on apoptosis of neuroadernergic neurons in a rat model of Parkinson’s disease

    F. Yadolahi, M. Mehrpour (Tehran, Islamic Republic of Iran)

    Objective: To investigate melatonin therapeutic potential effects in Parkinson’s disease. Background: Sleep disorders constitute major nonmotor features of Parkinson’s disease (PD) that have a substantial…
  • 2018 International Congress

    Characterization of the gastrointestinal dysfunction in mice overexpressing the human mutation (A53T) of alpha-synuclein

    S. Diwakarla, R. Constable, O. Artaiz, D. Finklestein, J. Berger, J. Furness (Melbourne, Australia)

    Objective: The aim of this study was to determine if mice overexpressing the human mutation of alpha-synuclein develop gastrointestinal (GI) dysfunction, and to understand the…
  • 2018 International Congress

    Clinical subtypes of Parkinson’s disease based on nonmotor symptoms: A cluster analysis

    X. Xu, P. Chan (Beijing, China)

    Objective: To classify patients with early Parkinson's disease based on nonmotor symptoms using a data-driven approach. Background: Heterogeneity of Parkinson’s disease provides the basis for…
  • 2018 International Congress

    Improvement of Levodopa-Responsive Chronic Pain after STN-DBS in Parkinson’s disease

    A. Gera, G. Pal (Chicago, IL, USA)

    Objective: To illustrate an example of an improvement in chronic pain, following bilateral subthalamic nuclei (STN) deep brain stimulation (DBS) surgery in a Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 162
  • 163
  • 164
  • 165
  • 166
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley